This inventor holds 2 USPTO granted patents. Top assignee: Debiopharm S.a.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Christine Deuschel: Innovator in Pharmaceutical Preparations
Introduction
Christine Deuschel is a notable inventor based in Trélex, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of stable oxaliplatinum preparations for parenteral administration. With a total of two patents to her name, her work is recognized for its innovative approach to drug formulation.
Latest Patents
Christine Deuschel's latest patents include a pharmaceutically stable oxaliplatinum preparation for parenteral administration. This invention focuses on creating a clear, colorless solution of oxaliplatinum that remains precipitate-free for an extended period. The preparation contains oxaliplatinum in a solvent at a concentration of at least 7 mg/ml, utilizing hydroxylated derivatives such as 1,2-propanediol, glycerol, maltitol, saccharose, and inositol. Another significant patent is for a pharmaceutical oxaliplatinum preparation that has undergone wet heat treatment with steam under pressure, ensuring stability and efficacy for parenteral use.
Career Highlights
Christine Deuschel is currently employed at Debiopharm S.A., a company known for its commitment to advancing pharmaceutical innovations. Her work at Debiopharm has allowed her to focus on developing cutting-edge solutions that enhance patient care and treatment outcomes.
Collaborations
Throughout her career, Christine has collaborated with esteemed colleagues such as Houssam Ibrahim and Henri Pourrat. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.
Conclusion
Christine Deuschel stands out as a pioneering inventor in the pharmaceutical industry, with her patents reflecting a commitment to improving drug formulations. Her contributions are vital to advancing medical treatments and enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
